SavedAdd your journal

Journals / Turkish Journal of Internal Medicine / 2026 / Volume: 4 Special Issue

COVID-19 Presenting with Diabetic Ketoacidosis: A case report

İffet Beril Gökmen(ACIBADEM UNIVERSITY, SCHOOL OF MEDICINE)0000-0003-4986-200X
Sidelya Ecem Yiğit(ACIBADEM UNIVERSITY, SCHOOL OF MEDICINE)0000-0002-9961-4066
Yıldız Okuturlar(ACIBADEM UNIVERSITY, SCHOOL OF MEDICINE)0000-0002-1994-0014
İftihar Köksal(ACIBADEM UNIVERSITY, SCHOOL OF MEDICINE)0000-0003-4892-8935
Pages
—
Publication Date
2022-04-01
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Herein we presented a case of diabetic ketoacidosis caused by COVID-19 infection.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Diabetic ketoacidosis (DKA) is one of the most common fatal complications of diabetes and is often associated with severe underlying disease.
📊
Key Findings & Data:The COVID-19 infection follows an intense course in patients with comorbidities such as diabetes.
💡
Conclusion & Impact:Herein we presented a case of diabetic ketoacidosis caused by COVID-19 infection.
🔬Design:Case Report
📍Scope:Comprehensive Sample
⚙️Variables:Covid-19 · Diabetes Mellitus · Diabetic Ketoacidosis

Abstract

Diabetic ketoacidosis (DKA) is one of the most common fatal complications of diabetes and is often associated with severe underlying disease. The COVID-19 infection follows an intense course in patients with comorbidities such as diabetes. Herein we presented a case of diabetic ketoacidosis caused by COVID-19 infection.

🔖

Cite This Article

Gökmen, İ. B., Yiğit, S. E., Okuturlar, Y., Köksal, İ. (2022). COVID-19 Presenting with Diabetic Ketoacidosis: A case report. Turkish Journal of Internal Medicine, Volume: 4 Special Issue. https://doi.org/10.46310/tjim.1073576

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (5)

  1. Pasquel FJ, Tsegka K, Wang H, Cardona S, Galindo RJ, Fayfman M, Davis G, Vellanki P, Migdal A, Gujral U, Narayan KMV, Umpierrez GE. Clinical outcomes in patients with isolated or combined diabetic ketoacidosis and hyperosmolar hyperglycemic state: A retrospective, hospital-based cohort study. Diabetes Care. 2020 Feb;43(2):349-57. doi: 10.2337/dc19-1168.
  2. Pal R, Banerjee M, Yadav U, Bhattacharjee S. Clinical profile and outcomes in COVID-19 patients with diabetic ketoacidosis: a systematic review of literature. Diabetes Metab Syndr. 2020 Nov-Dec;14(6):1563-9. doi: 10.1016/j.dsx.2020.08.015.
  3. Vellanki P, Umpierrez GE. Diabetic ketoacidosis risk during the COVID-19 pandemic. Lancet Diabetes Endocrinol. 2021 Oct;9(10):643-4. doi: 10.1016/S2213-8587(21)00241-2.
  4. Al-Kuraishy HM, Al-Gareeb AI, Alblihed M, Guerreiro SG, Cruz-Martins N, Batiha GE. COVID-19 in relation to hyperglycemia and diabetes mellitus. Front Cardiovasc Med. 2021 May 20;8:644095. doi: 10.3389/fcvm.2021.644095.
  5. Wu CT, Lidsky PV, Xiao Y, Lee IT, Cheng R, Nakayama T, Jiang S, Demeter J, Bevacqua RJ, Chang CA, Whitener RL, Stalder AK, Zhu B, Chen H, Goltsev Y, Tzankov A, Nayak JV, Nolan GP, Matter MS, Andino R, Jackson PK. SARS-CoV-2 infects human pancreatic β cells and elicits β cell impairment. Cell Metab. 2021 Aug 3;33(8):1565-76.e5. doi: 10.1016/j.cmet.2021.05.013.